SCHEMBL24997259

SCHEMBL24997259

O=C(CO[C@H]1C[C@@H](OC(F)(F)F)C1)NC1CCN(C(=O)Nc2ccc3cc(Cl)ccc3n2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATF4 P18848 7/20 0.43
▸ FAAH O00519 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MCHR1 Q99705 2/20 0.37
▸ CXCR3 P49682 1/20 0.36
▸ EPHX2 P34913 1/20 0.34
▸ CCNK O75909 1/20 0.34
▸ CCNA2 P20248 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CDK7 P50613 1/20 0.34
▸ CCNH P51946 1/20 0.34
▸ MNAT1 P51948 1/20 0.34
▸ CDK12 Q9NYV4 1/20 0.34
▸ MC4R P32245 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ ENPP2 Q13822 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24997931 0.92 ATF4 (0.44) ATF4FAAHLMNAL3MBTL1MEN1
SCHEMBL24998143 0.88 FAAH (0.41) ATF4FAAHCXCR3ENPP2HRH4
SCHEMBL24997981 0.88 ATF4 (0.40) ATF4LMNAKMT2AMCHR1NPC1
SCHEMBL30053049 0.88 ATF4 (0.40) ATF4LMNAKMT2AMCHR1NPC1
SCHEMBL24998141 0.84 FAAH (0.43) ATF4FAAHLMNAL3MBTL1CXCR3
SCHEMBL24997331 0.83 MEN1 (0.42) ATF4FAAHLMNAL3MBTL1MEN1
SCHEMBL24997261 0.81 ATF4 (0.43) ATF4LMNANPC1
SCHEMBL30053354 0.81 ATF4 (0.43) ATF4LMNANPC1
SCHEMBL24998294 0.81 CYP3A4 (0.45) ATF4FAAHLMNAL3MBTL1MEN1
SCHEMBL21390251 0.80 ATF4 (0.51) ATF4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230042881-A1 MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAY Praxis Biotech LLC 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230042881-A1 MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, ATF1, DDIT3 ATF4 1/4885FAAH 3049/4885LMNA 4342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback